The goal of this observational study is to screening for clinical, pathological and HLA features in patients with recurrent drug-induced liver injury. The main question it aims to answer is: Which patients with drug-induced liver injury need to be more cautious when re-dosing?
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Death/Liver transplantation
Timeframe: 1 year
Acute Liver Failure
Timeframe: 1 year
Recovery
Timeframe: 1 year